https://www.selleckchem.com/pr....oducts/ly2880070.htm
11, 0.20, and 0.33 for 3rd month, 6th month, and 12th month, respectively, P0.001) and lower PWV values (coefficient of -0.69, -0.63, and -0.34 for 3rd month, 6th month, and 12th month, respectively, P0.001), after the initiation of APAP treatment. We conclude that APAP treatment improves main lung function and arterial stiffness parameters in male patients with severe OSA over a 1 year follow-up. We conclude that APAP treatment improves main lung function and arterial stiffness parameters in male patients with severe OSA over
Like
Comment
Share
